Maren H. Harms

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Maren H. Harms, Henk R. van Buuren, Christophe Corpechot et al. · Journal of Hepatology · 2019 · 277 citations · Full text

Medicine, Internal Medicine, Surgery +9

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Carla Fiorella Murillo Perez, Maren H. Harms, Keith D. Lindor et al. · The American Journal of Gastroenterology · 2020 · 171 citations · Full text

Medicine, Internal Medicine, Hepatology +16

Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival

Aldo J. Montaño‐Loza, Bettina E. Hansen, Christophe Corpechot et al. · Gastroenterology · 2018 · 127 citations · Full text

Medicine, Internal Medicine, Hepatology +14

Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study

Elisabeth M. G. de Vries, Manon de Krijger, Martti Färkkilâ et al. · Hepatology · 2016 · 103 citations · Full text

Medicine, Internal Medicine, Pathology +17

Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome

Maren H. Harms, Willem J. Lammers, Douglas Thorburn et al. · The American Journal of Gastroenterology · 2017 · 93 citations · Full text

Medicine, Hematology, Internal Medicine +17